Magnendo
Robotic magnetic navigation for neurovascular interventions.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Seed | |
| Total Funding | 000k | ||
Magnendo is a medical technology company founded in 2024 by Yoonho Kim and Miki Rosenberg, spinning out of research conducted at MIT. The company is headquartered in Boston, USA, and focuses on developing robotic solutions to improve the treatment of neurovascular conditions like strokes and brain aneurysms.
The company's core technology is a robotic navigation system that uses a magnetically steerable guidewire. This system is designed to overcome the challenges of navigating the brain's complex and tortuous blood vessels, which can make conventional procedures time-consuming and risky. The technology embeds tiny magnetic particles into the tip of a soft guidewire, which is then controlled by an external, robotically manipulated magnet. This allows surgeons to precisely and safely steer the wire to hard-to-reach areas of the brain, potentially reducing procedure times by over 10 minutes in typical cases and up to 30 minutes in complex ones.
The founder and CEO, Yoonho Kim, began developing the technology during his PhD at MIT. He is joined by co-founder and Chief Development Officer Miki Rosenberg, formerly the VP of R&D in surgical robotics at Medtronic, and Chief Medical Officer Dr. Aman B. Patel, the Director of Endovascular Neurosurgery at Harvard/MGH. The company aims to make endovascular procedures faster and safer, reduce complications like vessel perforation, and standardize performance across physicians with varying experience levels. Ultimately, Magnendo envisions its platform enabling remote stroke treatments, allowing specialists at major medical centers to operate on patients in smaller, local hospitals.
Magnendo operates in the MedTech and therapeutic devices market. It generates revenue through its robotic platform, targeting comprehensive and primary stroke centers. The company secured pre-seed funding from investors including BASS Ventures and Kakao Ventures and has raised a total of $2.25M in a seed round.
Keywords: neurovascular intervention, robotic surgery, magnetic guidance, endovascular therapy, stroke treatment, brain aneurysm, medical devices, MedTech, guidewire technology, remote surgery